Geron (GERN) +5.8% premarket after BioTime (BTX) issues an open letter to GERN shareholders...

|About: Geron Corporation (GERN)|By:, SA News Editor

Geron (GERN) +5.8% premarket after BioTime (BTX) issues an open letter to GERN shareholders proposing a transaction between the two biopharma companies. Part of the proposal would allow GERN shareholders could own up to 45% of a new publicly traded company that would own GERN stem cell assets.